@MendozaRayman @neurointensivos @MGrecoMD @Lazanba @Auribarri @khaycock2 @poximuz @mike_grocott @mac_eden @RitwikBhatiaMD @deepak_neuro Etomidate inhibits 11‐beta‐hydroxylase. A previous Cochrane review documented an increased risk of adrenal insufficienc
RT @SCCMMichigan: The EvK Trial was an RCT assessing mortality in RSI using etomidate vs ketamine (https://t.co/QUsbu77NS2). Mortality was…
The EvK Trial was an RCT assessing mortality in RSI using etomidate vs ketamine (https://t.co/QUsbu77NS2). Mortality was lower with ketamine at day 7, but no difference at 28 days. Findings are consistent with a Cochrane review (https://t.co/0YqOE8QKWE).
RT @YukiKotani5: @EM_RESUS In intensive care settings, several meta-analyses showed a trend toward increased mortality in patients receivin…
@EM_RESUS In intensive care settings, several meta-analyses showed a trend toward increased mortality in patients receiving etomidate. https://t.co/bLq9XM26VQ https://t.co/eCR9wBbqf2 https://t.co/u07ng8hKx7
@MZasadowski @azevedo_lcp @arthur_alb1 @yourICM @mj0b @audreydejongMD @JABERSamir3 @Dr_Cit @oriolrocag @FOAMecmo @JohnCSakles @SheilaMyatra @otavio_ranzani @f_g_zampieri @AnaCarolPecanha I agree There is a trend toward increased mortality in several meta-a
@OllyHamilton @yourICM @FOAMecmo @CGSNabzdykMD @pwierusz @gretchensacha @CMageePharmD @Dre_pharmd @tahan_dr @INTUBEstudy @avkwong Etomidate is not available in Japan😅 Yes, the risk of adrenal insufficiency is a big issue. In addition, meta-analyses reporte
@fuzzymittens @bobfunn @OBsleepmerchant @CAS_RegAnes So your answer is based on a study with 30 patients. This is not a data strong enough to stop using this drug. That study does not support what you say. https://t.co/i6dDjy13kb
Na literatura é fácil encontrar trabalhos chegando a resultados distintos sobre essa questão. Muitos derivam de estudos observacionais, análises post hoc e revisões restrospectivas, com poucos pacientes incluídos em ensaios clínicos randomizados https://t
Now "Single induction dose of etomidate vs other induction agents for endotracheal intubation in critically ill pt" https://t.co/6a8zu3nIQQ
Single induction dose of etomidate vs other induction agents for endotracheal intubation in critically ill patients http://t.co/MhjgbpHWUl
Single induction dose of etomidate versus other induction agents for endotracheal intubation-http://t.co/umzTcumAeX #cochranecollab
More research? #RSI Induction dose of etomidate versus other agents for endotracheal intubation The Cochrane Library http://t.co/QUboegKXkK
最近集中治療関係のレビューが多いコクランから、重症患者の気管挿管時のEtomidate投与について。副腎障害を起こすことが知られている薬ですが、ICU滞在日数や昇圧剤投与日数が増えることはない模様。 http://t.co/gg0xbGQTCs
最近集中治療関係のレビューが多いコクランから、重症患者の気管挿管時のEtomidate投与について。副腎障害を起こすことが知られている薬ですが、ICU滞在日数や昇圧剤投与日数が増えることはない模様。 http://t.co/gg0xbGQTCs
Sigue la discusión con etomidato! Que piensan ustedes? http://t.co/AfD3jZyVr5
RT @midazolamb: Etomidate: avoid in the ICU or preferred agent for intubation? What do you all think? http://t.co/SFNoJekupC
RT @midazolamb: Etomidate: avoid in the ICU or preferred agent for intubation? What do you all think? http://t.co/SFNoJekupC
Etomidate: avoid in the ICU or preferred agent for intubation? What do you all think? http://t.co/byUbSf4SGk
YBUde etomidattan korkmalı mı? Kritik hastada etomidat RSI de tercih edilmemeli mi? Etomidat sorunsalı devamediyor... http://t.co/6g10xwECpC
YBUde etomidattan korkmalı mı? Kritik hastada etomidat RSI de tercih edilmemeli mi? Etomidat sorunsalı devamediyor... http://t.co/6g10xwECpC
Etomidate for endotracheal intubation in critically ill patients. @cochranecollab @CochranePC http://t.co/ISc6yyB9C3
Etomidat: Mortalite üzerine kanıtsızlığa karşın, az da olsa adrenal bez ve multiorgan disfonk. riskini arttırıyor. http://t.co/ugzIJ0Z2nJ
Cochrane on Etomidate: http://t.co/UcImkR54ND Because we needed another review...
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
"Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill." http://t.co/EJzOxxhyGA
"Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill." http://t.co/EJzOxxhyGA
"Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill." http://t.co/EJzOxxhyGA
"Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill." http://t.co/EJzOxxhyGA
"Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill." http://t.co/EJzOxxhyGA
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
The latest (but not last) word on etomidate for induction of critically ill http://t.co/6ll6sbSlIf http://t.co/6OieaPBvCy
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Is this what we've been waiting for? @CochraneLibrary summary of etomidate use for RSI in the ED: http://t.co/GlqB3a8McD HT @cabreraERDR
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Is this what we've been waiting for? @CochraneLibrary summary of etomidate use for RSI in the ED: http://t.co/GlqB3a8McD HT @cabreraERDR
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Is this what we've been waiting for? @CochraneLibrary summary of etomidate use for RSI in the ED: http://t.co/GlqB3a8McD HT @cabreraERDR
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Etomidate for RSI in the ED: no change in mortality, ICU use or time in vent http://t.co/iYTUyEDV0Y #FOAMed @cochranecollab
Is this what we've been waiting for? @CochraneLibrary summary of etomidate use for RSI in the ED: http://t.co/GlqB3a8McD HT @cabreraERDR